FOSCHI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 21.928
NA - Nord America 10.047
AS - Asia 9.887
AF - Africa 762
SA - Sud America 718
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 14
Totale 43.393
Nazione #
IT - Italia 14.467
US - Stati Uniti d'America 9.813
SG - Singapore 2.917
CN - Cina 2.479
VN - Vietnam 2.235
GB - Regno Unito 1.742
DE - Germania 1.161
FR - Francia 879
HK - Hong Kong 737
SE - Svezia 704
NL - Olanda 612
UA - Ucraina 547
IN - India 539
BR - Brasile 503
RU - Federazione Russa 409
IE - Irlanda 296
ZA - Sudafrica 193
KR - Corea 186
FI - Finlandia 175
CI - Costa d'Avorio 171
JP - Giappone 158
CH - Svizzera 148
CA - Canada 138
EE - Estonia 115
TG - Togo 97
NG - Nigeria 92
AR - Argentina 89
ID - Indonesia 84
ES - Italia 81
PL - Polonia 79
GR - Grecia 68
PH - Filippine 68
SC - Seychelles 68
AT - Austria 63
TH - Thailandia 63
BE - Belgio 62
BG - Bulgaria 57
TR - Turchia 56
MX - Messico 48
HR - Croazia 44
JO - Giordania 44
IQ - Iraq 41
TW - Taiwan 40
RO - Romania 38
BD - Bangladesh 35
EG - Egitto 35
CL - Cile 32
IR - Iran 32
AU - Australia 31
PK - Pakistan 30
EC - Ecuador 29
UZ - Uzbekistan 26
AL - Albania 22
BB - Barbados 21
MA - Marocco 20
LT - Lituania 19
SA - Arabia Saudita 18
CO - Colombia 17
MY - Malesia 17
SK - Slovacchia (Repubblica Slovacca) 17
CZ - Repubblica Ceca 16
HU - Ungheria 15
KE - Kenya 15
KZ - Kazakistan 15
PY - Paraguay 15
PE - Perù 14
TN - Tunisia 14
DK - Danimarca 13
SM - San Marino 13
DZ - Algeria 12
GH - Ghana 12
LU - Lussemburgo 11
NO - Norvegia 10
PT - Portogallo 10
RS - Serbia 10
IL - Israele 9
LB - Libano 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
BA - Bosnia-Erzegovina 6
CM - Camerun 6
UY - Uruguay 6
VE - Venezuela 6
XK - ???statistics.table.value.countryCode.XK??? 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
CY - Cipro 5
MN - Mongolia 5
SI - Slovenia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
HN - Honduras 4
IS - Islanda 4
NZ - Nuova Zelanda 4
OM - Oman 4
PA - Panama 4
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MT - Malta 3
Totale 43.330
Città #
Singapore 1.999
Southend 1.440
Milan 1.266
Ashburn 1.079
Rome 929
Hong Kong 702
Chandler 696
Bologna 671
Fairfield 572
Ann Arbor 570
Santa Clara 501
Ho Chi Minh City 484
San Jose 434
Hanoi 427
Houston 345
Princeton 342
Beijing 341
Hefei 333
Frankfurt am Main 305
Wilmington 293
Dublin 277
Naples 268
Seattle 259
Turin 258
Boardman 247
Woodbridge 247
Dong Ket 240
Lauterbourg 214
Padova 208
Los Angeles 198
Florence 191
Palermo 191
Bari 173
Cambridge 172
Abidjan 171
New York 161
Nanjing 156
Catania 146
Westminster 145
Berlin 141
Seoul 134
Council Bluffs 127
Dallas 125
Helsinki 125
Redmond 124
Tokyo 110
Genoa 105
Medford 102
Lomé 97
Buffalo 93
Verona 92
Jinan 86
Dearborn 83
Redondo Beach 81
Brescia 79
Guangzhou 75
Abeokuta 72
Saint Petersburg 72
Shenyang 70
Parma 69
Da Nang 65
Modena 64
Toronto 62
Cagliari 61
San Diego 60
Haiphong 59
Shanghai 58
Changsha 56
São Paulo 54
Hebei 53
Napoli 52
Sofia 52
Treviso 52
Orem 51
Perugia 48
Jakarta 45
Nanchang 44
Redwood City 44
Amman 43
Pescara 43
London 41
Tianjin 41
Bergamo 40
Bolzano 40
Paris 40
Pisa 40
Reggio Emilia 39
Trieste 39
Chicago 38
Falls Church 37
Venice 37
Brussels 36
Nuremberg 36
Basingstoke 35
Ancona 34
Bengaluru 34
Johannesburg 34
Des Moines 33
Livorno 33
Messina 33
Totale 21.519
Nome #
IMPIEGO DI REAL-TIME PCR PER LA DIAGNOSI DI LABORATORIO DI INFEZIONI DA CHLAMYDIA TRACHOMATIS E NEISSERIA GONORRHOEAE 2.764
Epidemiologia delle infezioni genitali da Mollicutes 1.567
Gardnerella vaginalis in donne con diverse condizioni cliniche 1.398
PERFORMANCE DEL WESTERN BLOT COMPARATIVO NELLA DIAGNOSI DI TOXOPLASMOSI CONGENITA IN NEONATI DA MADRI CON SIEROCONVERSIONE TARDIVA 1.305
LIMITAZIONE DELL’USO DELL’IMMUNOBLOT PER LA CONFERMA DI ANTICORPI ANTI-HCV DOPO INTRODUZIONE DEL TEST VIDAS® ANTI-HCV 1.247
MICOPLASMI UROGENITALI IN NEONATI PREMATURI 923
Mollicutes e microbiota vaginale 866
Caratterizzazione fenotipica e genotipica di ceppi di Staphylococcus aureus isolati in corso di batteriemia 786
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 714
In vitro anti-Candida activity of a Spirulina platensis extract: a new approach for the treatment of fungal infections? 675
STUDIO IN VITRO DELL’ATTIVITA’ ANTI-FUNGINA DI UN ESTRATTO DI SPIRULINA PLATENSIS: UN NUOVO APPROCCIO PER IL TRATTAMENTO DELLE CANDIDOSI MUCO-CUTANEE? 674
SIFILIDE: UN PROBLEMA ANCORA ATTUALE 502
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 484
PREVALENZA DI INFEZIONI RETTALI E FARINGEE DA CHLAMYDIA TRACHOMATIS E NEISSERIA GONORRHOEAE IN UNA POPOLAZIONE AD ALTO RISCHIO 474
VALUTAZIONE DEL SISTEMA IMMULITE® 2000 PER LO SCREENING SIEROLOGICO DELLE INFEZIONI DA TOXOPLASMA GONDII, CYTOMEGALOVIRUS E ROSOLIA 472
DIAGNOSI MOLECOLARE DI LINFOGRANULOMA VENEREO SU TAMPONI RETTALI. 446
SORVEGLIANZA DI TOXOPLASMOSI CONGENITA PRESSO IL POLICLINICO S. ORSOLA-MALPIGHI, BOLOGNA 375
VALUTAZIONE DEL VERIGENE GRAM-NEGATIVE BLOOD CULTURE TEST PER L’IDENTIFICAZIONE DI SPECIE E DEI DETERMINANTI DI RESISTENZA AI BETA-LATTAMICI DA FLACONI POSITIVI DI EMOCOLTURA 368
ALTERAZIONI DEL MICROBIOMA FARINGEO IN CORSO DI INFEZIONI DA NEISSERIA GONORRHOEAE 345
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 337
MICROBIOTA VAGINALE IN CORSO DI INFEZIONI DEL TRATTO GENITALE 322
TOXOPLASMOSI ACUTA IN PAZIENTE IMMUNOCOMPETENTE: QUAL’E’ IL RUOLO DEGLI ESAMI DI BIOLOGIA MOLECOLARE? 321
Studio del profilo metabolico di ceppi di Klebsiella pneumoniae mediante spettroscopia di risonanza magnetica nucleare (1H-NMR) 306
Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study 291
Isolation of vaginal lactobacilli and characterization of anti-candida activity 289
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 283
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 280
RILEVAZIONE DELLA STRUTTURA MOSAICO DEL GENE PENA IN SEDE ORO-FARINGEA 278
Metaboloma urinario in donne con infezione da Chlamydia trachomatis 274
VALUTAZIONE DELLE PERFORMANCE ANALITICHE DI IMMULITE® 2000 E BIOPLEX® 2200 PER LO SCREENING SIEROLOGICO DELLE INFEZIONI DA TOXOPLASMA GONDII, CYTOMEGALOVIRUS E VIRUS DELLA ROSOLIA 270
Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice 263
In vitro activity of Spirulina platensis water extract against different Candida species isolated from vulvo-vaginal candidiasis cases. 255
Impact of meropenem on Klebsiella pneumoniae metabolism 244
Pharyngeal Chlamydia and gonorrhea: a hidden problem 242
Mosaic structure of the penA gene in the oropharynx of men who have sex with men negative for gonorrhoea 235
Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results 235
Urine metabolome in women with Chlamydia trachomatis infection 227
Sexually transmitted rectal infections in a cohort of 'men having sex with men' 226
Pre-Pregnancy Diet and Vaginal Environment in Caucasian Pregnant Women: An Exploratory Study 222
Survival and death of intestinal cells infected by Chlamydia trachomatis 221
Diversity of vaginal microbiome and metabolome during genital infections 221
Distribution of genital Mollicutes in the vaginal ecosystem of women with different clinical conditions 217
Activity of cathelicidin peptides against Simkania negevensis 208
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 207
Low-dose doxycycline induces Chlamydia trachomatis persistence in HeLa cells 206
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 205
UTILIZZO DI SL SOLUTION, COPAN, PER LA DIAGNOSI MOLECOLARE DI INFEZIONI RESPIRATORIE DA CHLAMYDIA PNEUMONIAE E MYCOPLASMA PNEUMONIAE 204
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 204
Anti-bacterial activity of 17 strains of lactobacilli against elementary bodies of Chlamydia trachomatis 198
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 197
Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection 197
Epidemiologia delle infezione faringee da Chlamydia trachomatis e Neisseria gonorrhoeae 196
DETERMINAZIONE DELLA PRODUZIONE DI CARBAPENEMASI IN ENTEROBATTERI CON RIDOTTA SENSIBILITA’ AI CARBAPENEMI MEDIANTE METODICA LC-MS (LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY) 191
Evaluation of cytokines and matrix metalloproteinases genes expression in genital organs after vaginal exposure to Chlamydia muridarum 189
A Deep Look at the Vaginal Environment During Pregnancy and Puerperium 188
A Case of Reactive Arthritis Associated With Lymphogranuloma Venereum Infection in a Woman 188
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription. 187
Vaginal metabolic profiles during pregnancy: Changes between first and second trimester 187
Distribution of ermB, ermF, tet(W), and tet(M) resistance genes in the vaginal ecosystem of women during pregnancy and puerperium 187
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 186
Pharyngeal chlamydia and gonorrhoea: a hidden problem. 185
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 183
First-Void Urine Microbiome in Women with Chlamydia trachomatis Infection 181
A year in a sexually-transmitted disease (STD) outpatients clinic in Italy: prevalence and characteristics of chlamydia, gonorrhoea and syphilis infections 180
In-vitro effect of vaginal lactobacilli against group B Streptococcus 177
Evaluation of the Versant CT/GC DNA 1.0 Assay (kPCR) for the Detection of Extra-Genital Chlamydia trachomatis and Neisseria gonorrhoeae Infections. 172
Rectal Microbiota Associated With Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Men Having Sex With Other Men 172
UN CASO DI FEBBRE REUMATICA ACUTA: CARATTERISTICHE CLINICHE E MICROBIOLOGICHE 171
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 170
Contribution of a comparative western blot method to early postnatal diagnosis of congenital syphilis 170
Chlamydia trachomatis serovar distribution and other sexually transmitted coinfections in subjects attending a STD Outpatients Clinic in Italy. 167
Valutazione del test Aptima Combo 2 per la diagnosi molecolare di infezioni da Chlamydia trachomatis e Neisseria gonorrhoeae 167
Cap. 4- IL MICROBIOMA OCULARE E IMPATTO SUL SISTEMA IMMUNE 167
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 166
New Insights into Vaginal Environment During Pregnancy 166
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 165
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 165
Rescue of Chlamydia trachomatis tryptophan depletion with indole 165
Prevalence and antimicrobial resistance of genital Mollicutes in Italy over a two-year period 164
Chlamydial conjunctivitis in newborns: Case report and screening opportunities 163
Gardnerella vaginalis clades in pregnancy: New insights into the interactions with the vaginal microbiome 163
Metabolic profiling of Candida clinical isolates of different species and infection sources 162
Evaluation of the Aptima assays for the detection of bacterial sexually transmitted infections in a selected population of women 161
Vaginal metabolites in postmenopausal women with or without vulvo-vaginal atrophy at baseline and after ospemifeme and systemic hormone treatment 161
Anti-chlamydial activity of vaginal fluids: new evidence from an in vitro model 159
Non-pathogenic Neisseria species of the oropharynx as a reservoir of antimicrobial resistance: a cross-sectional study 158
Chlamydia trachomatis Serovar Distribution and Other Sexually Transmitted Coinfections in Subjects Attending a STD Outpatients Clinic in Italy 158
Metabolic fingerprints of different clinical conditions affecting women’s genital tract 158
Insights into penicillin-induced Chlamydia trachomatis persistence 158
Role of D(-)-Lactic Acid in Prevention of Chlamydia trachomatis Infection in an In Vitro Model of HeLa Cells 157
Chlamydia trachomatis infection prevalence and serovar distribution in a high-density urban area in the North of Italy 156
Vaginal Lactobacilli Reduce Neisseria gonorrhoeae Viability through Multiple Strategies: An in Vitro Study. 156
Lactobacillus crispatus interferes with Chlamydia trachomatis infectivity through modulation of integrin exposure in cervical cells 154
Evaluation of BD ProbeTec™ CT/GC Qx DNA Amplified assay for the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections 153
Vaginal microbiome signatures in Chlamydia trachomatis infected women 151
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 151
Valutazione del sistema BD ProbeTec CT/GC Qx DNA Amplified assay su piattaforma BD Viper LT per la diagnosi molecolare di infezioni da Chlamydia trachomatis e Neisseria gonorrhoeae 150
11C-Choline Small Animal PET in Experimental Chlamydia muridarum Infection. 150
Effect of sugars on Chlamydia trachomatis infectivity 150
Carbapenemase-producing Enterobacterales: changing epidemiology in a highly endemic Italian area 150
Totale 32.501
Categoria #
all - tutte 95.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.585 0 0 0 0 0 0 0 0 0 331 330 924
2021/20224.277 397 253 229 307 409 272 223 302 230 255 724 676
2022/20235.482 507 543 339 617 390 385 327 359 794 353 491 377
2023/20244.865 290 362 437 483 478 494 456 329 281 437 430 388
2024/20258.108 639 948 726 604 1.040 572 616 591 472 496 423 981
2025/202611.560 942 1.066 1.079 1.047 1.339 753 1.419 643 2.303 969 0 0
Totale 44.139